On April 21, the U.S. Supreme Court will hear oral arguments in Minerva Surgical Inc. v. Hologic Inc. The case turns on application of assignor estoppel, a centuries-old doctrine that precludes assignors and their privies from attacking the validity of the patent rights they assign.

Click here to read the full article.

This article originally appeared in Law360.